Transactions
2
Insider / U S PHYSICAL THERAPY INC /NV
Gilmartin Kathleen A
Director at U S PHYSICAL THERAPY INC /NV
- Company
- U S PHYSICAL THERAPY INC /NV
- Ticker
- USPH
- First filing on record
- November 24, 2025
- Latest trade on record
- May 19, 2026
- SEC filings
- EDGAR ↗
Gilmartin Kathleen A, Director at U S PHYSICAL THERAPY INC /NV, has disclosed 2 transactions in USPH since November 24, 2025: 1 purchase (1 open-market buy) and 0 sales, worth about $418K at the reported prices. The latest was filed May 20, 2026, 1 day after the trade.
Open-market buys
1
Sales
0
Avg. disclosure lag
2.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Gilmartin Kathleen A made 1 purchase worth $276K and no sales, plus 1 other transaction. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Gilmartin Kathleen A has traded 1 stock on record; the largest by dollars is USPH.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 2,306 | $142K |
| P | Open-market purchase | 1 | 4,000 | $276K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 1 | 0 | 0 |
| 2025 | 1 | 1 · $276K | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| USPH | Other A | May 19, 2026 | May 20, 2026 | 1d | 2,306 | $62 | $142K | Form 4 ↗ | ||
| USPH | Buy P | November 20, 2025 | November 24, 2025 | 4d | 4,000 | $69 | $276K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 20, 2026 | Form 4 | 0001193125-26-232573 | 1 | published | EDGAR ↗ |
| November 24, 2025 | Form 4 | 0001193125-25-293697 | 1 | published | EDGAR ↗ |
Other insiders at U S PHYSICAL THERAPY INC /NV
- Harris Bernard A Jr Director 7 rows
- REEVE GRAHAM D. COO 7 rows
- Minan Peter Francis Director 5 rows
- Binstein Richard EVP Gen'l Counsel & Secretary 3 rows
- CURTIS JASON TRAVIS Interim CFO 2 rows
- HENDRICKSON CAREY P Chief Financial Officer 2 rows
- Motsenbocker Anne Director 2 rows
- Williams Eric Joseph President and COO 2 rows
- Davis Myra Director 1 row
- Etta Nchacha EVP & Chief Financial Officer 1 row
Everyone on file, with contracts and lobbying under the company's name: U S PHYSICAL THERAPY INC /NV.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 2 | November 24, 2025 | May 20, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.